Literature DB >> 28409324

Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody.

Julie Pelletier1, Hervé Agonsanou1,2, Ninotchska Delvalle3, Michel Fausther1,2,4, Mabrouka Salem1,2, Brian Gulbransen3, Jean Sévigny5,6.   

Abstract

Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) is an ectonucleotidase that modulates P2 receptor activation by hydrolyzing ATP to ADP. In rodents, NTPDase2 is expressed by several specialized cell types such as vascular adventitial cells, neuroglial cells, hepatic portal fibroblasts, gustatory type I cells, and cells within the connective tissues of reproductive and gastrointestinal organs. Much less is known regarding the expression and function of NTPDase2 in humans. Here, we developed specific research tools to study human NTPDase2. We generated mouse monoclonal antibodies and rabbit polyclonal antibodies specific to human NTPDase2 and validated their specificity by western blot, immunocytochemistry, immunohistochemistry, and flow cytometry. In addition, one monoclonal antibody named hN2-D5 s specifically inhibits human NTPDase2 enzymatic activity but not mouse nor rat NTPDase2. Using these antibodies, NTPDase2 immunoreactivity was detected on glial cells of the human enteric nervous system suggesting a function of the enzyme in intestinal motility. In conclusion, the new antibodies described in our work are novel tools that will enhance future studies of NTPDase2 expression and function in humans.

Entities:  

Keywords:  Human NTPDase2; Inhibitor; Monoclonal and polyclonal antibodies; cDNA immunization

Mesh:

Substances:

Year:  2017        PMID: 28409324      PMCID: PMC5563290          DOI: 10.1007/s11302-017-9561-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  34 in total

1.  Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2.

Authors:  Aileen F Knowles; Wei-Chieh Chiang
Journal:  Arch Biochem Biophys       Date:  2003-10-15       Impact factor: 4.013

2.  Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

Authors:  Michel Fausther; Joanna Lecka; Elwy Soliman; Gilles Kauffenstein; Julie Pelletier; Nina Sheung; Jonathan A Dranoff; Jean Sévigny
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-01       Impact factor: 4.052

3.  Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds.

Authors:  Dianna L Bartel; Susan L Sullivan; Elise G Lavoie; Jean Sévigny; Thomas E Finger
Journal:  J Comp Neurol       Date:  2006-07-01       Impact factor: 3.215

4.  Role of the ectonucleotidase NTPDase2 in taste bud function.

Authors:  Aurelie Vandenbeuch; Catherine B Anderson; Jason Parnes; Keiichi Enjyoji; Simon C Robson; Thomas E Finger; Sue C Kinnamon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

5.  A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay.

Authors:  A A Baykov; O A Evtushenko; S M Avaeva
Journal:  Anal Biochem       Date:  1988-06       Impact factor: 3.365

6.  Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8.

Authors:  Michel Fausther; Joanna Lecka; Filip Kukulski; Sébastien A Lévesque; Julie Pelletier; Herbert Zimmermann; Jonathan A Dranoff; Jean Sévigny
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-11-09       Impact factor: 4.052

7.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

8.  Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.

Authors:  Andreas Brunschweiger; Jamshed Iqbal; Frank Umbach; Anja B Scheiff; Mercedes N Munkonda; Jean Sévigny; Aileen F Knowles; Christa E Müller
Journal:  J Med Chem       Date:  2008-07-17       Impact factor: 7.446

9.  Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.

Authors:  S A Lévesque; E G Lavoie; J Lecka; F Bigonnesse; J Sévigny
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

10.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

View more
  4 in total

1.  Cortical interlaminar astrocytes across the therian mammal radiation.

Authors:  Carmen Falcone; Marisol Wolf-Ochoa; Sarwat Amina; Tiffany Hong; Gelareh Vakilzadeh; William D Hopkins; Patrick R Hof; Chet C Sherwood; Paul R Manger; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  J Comp Neurol       Date:  2019-01-25       Impact factor: 3.215

2.  Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line.

Authors:  Julia Biz Willig; Débora Renz Barreto Vianna; Aline Beckenkamp; Liziane Raquel Beckenkamp; Jean Sévigny; Márcia Rosângela Wink; Andréia Buffon; Diogo André Pilger
Journal:  Purinergic Signal       Date:  2020-01-18       Impact factor: 3.765

Review 3.  E-NTPDases: Possible Roles on Host-Parasite Interactions and Therapeutic Opportunities.

Authors:  Lisvane Paes-Vieira; André Luiz Gomes-Vieira; José Roberto Meyer-Fernandes
Journal:  Front Cell Infect Microbiol       Date:  2021-11-09       Impact factor: 5.293

4.  A Simple and Efficient Genetic Immunization Protocol for the Production of Highly Specific Polyclonal and Monoclonal Antibodies against the Native Form of Mammalian Proteins.

Authors:  Julie Pelletier; Hervé Agonsanou; Fabiana Manica; Elise G Lavoie; Mabrouka Salem; Patrick Luyindula; Romuald Brice Babou Kammoe; Jean Sévigny
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.